CompletedEUCTR 2021-003588-85

Individualized care with antipsychotics in patients suffering from schizophrenia spectrum disorders- How to conciliate plasma concentrations, clinical response and genetic factors ?

This historical record does not confirm current site availability.

Historical research recordBelgium

The study in practice

Understand this study

What did researchers investigate?

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments. Check the source details below for country statuses and any transfer to CTIS.

Listed locations: Belgium
Study phase: Phase 4

Get this study by email

Study clarity

Study information

Study start dateNot clearly listed

Recruitment status: Completed
Enrollment listed in the registry: Not clearly listed
Sponsor: UCLouvain
Sponsor type: Unknown or unclear
Study type: Drug
Intervention type: Drug
Study phase: Phase 4
Locations: Belgium
Age range: Not clearly listed
Official registry ID: EUCTR 2021-003588-85
Official title: Show the full official title
Individualized care with antipsychotics in patients suffering from schizophrenia spectrum disorders- How to conciliate plasma concentrations, clinical response and genetic factors ?

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Belgium

Registry details

Historical country statuses

Belgium — Completed

Interested in joining this study?

FAQ

Questions about this study

Who is behind this study?

The study sponsor is UCLouvain.

Want to explore more studies?

Explore studies